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AngiogenesisHyperbaric oxygen therapy (HBO) is suggested to promote angiogenesis during wound healing, but the
mechanisms involved are not understood. This study used a novel isolated blood vessel preparation to
explore the effects of air, normobaric oxygen or hyperbaric oxygen (2.2 ATA for 90 min) on the angiogenesis
factor, vascular endothelial growth factor (VEGF), nitrite and nitrate (NOx), lactate dehydrogenase (LDH) and
lactate release from the tissue in normal Krebs Ringer, and the Ringer supplemented with either L-arginine,
or 15 mM lactate to mimic a wound environment, or both (L-arginine+lactate). The in vitro blood vessel
preparation remained viable during all experiments. There were no effects of HBO treatment on any of the
parameters measured in normal Krebs Ringer, but some treatment-dependent effects were observed in
supplemented Krebs Ringer. In the lactate supplemented Krebs Ringer, medium LDH levels increased in
response to either normobaric oxygen (NBO) or HBO, compared to air alone. There were also small, but
statistically signiﬁcant increases in total glutathione due to HBO treatment, compared to NBO or air in the
lactate supplemented medium, and in the combined supplement. There were no effects of HBO on NOx,
changes in external medium lactate levels, or tissue VEGF in any of the Krebs Ringers tested. However, post
treatment increases in VEGF were observed in the lactate supplemented medium, and for lactate release into
the medium for the combined supplement. We conclude that HBO does not cause NO or VEGF production
from the blood vessel in normal Krebs Ringer, but the data from supplemented medium show that the
response of the tissue is subtly affected by the chemical environment around the blood vessel, and the tissue
is more responsive to HBO when wound conditions are mimicked.© 2009 Elsevier B.V. All rights reserved.1. IntroductionHyperbaric oxygen (HBO) therapy is the administration of 100%
oxygen at more than one atmosphere. Clinical application and
experimental trials of HBO treatment on chronic wounds have
shown new blood vasculature formation and blood ﬂow improvement
in granulation tissue [1–4]. Although in vivo studies have provided
evidence that HBO promotes angiogenesis in chronic wound, the
mechanisms of how HBO therapy facilitates angiogenesis are far from
understood.
Angiogenesis is a highly orchestrated event involving the
endothelium of the blood vessel, the underlying smooth muscle
cells, and a diverse array of angiogenesis factors. Of these, vascular
endothelial growth factor (VEGF) is considered one of the most
important promoters of angiogenesis [reviews, 5–9]. Nitric oxide
release from smoothmuscle cells in the vessel wall is implicated in the
signalling cascade that results in VEGF production [6,8] and the
promotion of angiogenesis. The wound environment is ofteny).
ll rights reserved.characterised by reduced oxygen tensions, acidic pH and the presence
of metabolites from glycolysis such as lactate [e.g., 10,11]. This
chemical environment in the wound is therefore likely to affect the
local production of reactive oxygen species (ROS) such as superoxide
and hydrogen peroxide [12]. Modulation of ROS generation has been
implicated in the activation of VEGF and angiogenesis [13].
The moderate pressures (about 2 ATA) and durations (about
90 min) used in multiple HBO therapy for patients with chronic
wounds do not cause acute oxidative stress or disturbances to
haematology [14,15], but promote a beneﬁcial level of angiogenesis
and tissue repair [3,4]. One hypothesis is that the HBO therapy causes
low or moderate ROS production, and that these ROS act as signalling
molecules, perhaps via NO and VEGF, to promote angiogenesis
[13,16,17].
However, direct effects of oxygen and/or pressure on NO and VEGF
release, and thus angiogenesis, also cannot be excluded. Thus there
may be at least two major modes of HBO-dependent initiation of
angiogenesis. In patients this is further complicated by the fact that,
prior to HBO therapy, the initial wound is likely to generate ROS via
inﬂammation reactions. The presence of anaerobic metabolites and
low pH in this initial woundmight also inﬂuence NO chemistry, or the
ability of the endothelium to release VEGF; and therefore the initiation
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study, we attempt to unravel this problem by exploring NO, VEGF, and
ROS effects during HBO treatment in two very different situations; (i)
in normal physiological solutions, and (ii), in a solution with elevated
lactate levels to mimic the wound environment [10,11]. Our experi-
mental approach uses a novel isolated blood vessel preparation, so that
the local effects of NO and VEGF production by the endothelium can be
investigated, without the complication of other systemic responses
found in vivo. In addition, we also ensure the ability of cells to produce
NO in some experiments by adding L-arginine, which serves as a
physiological precursor for NO formation in blood vessels [18,19].
2. Materials and methods
Male Sprague Dawley rats (350–400 g, n=60) were purchased
fromHarlan UK Ltd (Shaw's Farm Blackthorn, Bicester, UK). Theywere
kept in a 12 h dark:12 h light cycle and had free access to food and
water before tissue collection. Experiments were conducted in
accordance with ethical approval. All chemicals except those other-
wise speciﬁed were obtained from Sigma Aldrich (Poole, UK).
2.1. Experimental design
Rats were euthanized with an intraperitoneal injection of Sagatal
(90 mg kg−1 body weight; Rhône Mérieux Limited, Harlow, Essex,
UK). Once the aorta (8–10 cm) had been removed, it was washed in
250ml of ice-cold phosphate-buffered saline (PBS) and then spread in
a culture dish with 10 ml of modiﬁed Krebs Ringer solution
(composition in mM: NaCl 118.6, KCl 4.7, CaCl2 2.5, MgSO4 1.2,
KH2PO4 1.2, NaHCO3 25.1, HEPES 10, glucose 10, pH 7.4) and any
remaining fat was carefully removed from the exterior of the blood
vessel. The aorta was then sectioned into 1 cm segments, and these
were randomly placed (one per well) in 6-well tissue culture plates
(Nunclon Delta SI, Nunc, InterMed, Denmark) with each well
containing 6 ml of either unsupplemented Krebs Ringer solution
(normal control), or Krebs Ringer supplemented with 100 μM L-
arginine (‘+arg.’), or 15 mM sodium L-lactate (‘+lac.’), or both
(‘+lac. +arg.’) in order to mimic the wound environment [20–22].
The temperature was maintained at 37 °C throughout. Segments of
aorta from one rat were used for each medium in each trial.
Segments of aorta were allowed to equilibrate for 30 min before
oxygen treatment; they were then randomly assigned to exposure to
air at 1 ATA (‘air’) or 100% oxygen at 1 ATA (‘NBO’) or 100% oxygen at
2.2 ATA (‘HBO’). After 90 min exposure, the aorta segments were
allowed to recover in normobaric air for 4 h. Tissue and medium
samples were collected at the end of the 30 min equilibration (‘Pre’),
immediately post treatment (‘Post’) and 4 h post treatment (‘4 h
Post’). All tissue and medium samples were snap-frozen in liquid
nitrogen, and stored at −80 °C until used for analysis.
2.2. Biochemical analysis
Several biochemical parameters were measured during the study.
Lactate dehydrogenase (LDH) release to the medium was used to
assess viability, whilst lactate accumulation in the medium was used
to assess anaerobic metabolism. The possibility of oxidative stress
during oxygen exposure was monitored by measuring total glu-
tathione levels in the medium. Total content of nitrite and nitrate
(NOx) in the mediumwas measured as a surrogate for NO production
by the tissue. Since NO and lactate are potential stimulatory factors for
vascular endothelial growth factor (VEGF) production, the levels of
VEGF in both the medium and the tissue were tested.
2.2.1. Lactate dehydrogenase
Lactate dehydrogenase (LDH) activity was measured essentially
according to [23]. One hundredmicrolitres of 21 mM sodium pyruvatesolution was rapidly added into a 4 ml cuvette which already
contained a mixture of 0.3 ml medium sample or tissue homogenate,
2.5 ml phosphate buffer (0.1 M, pH 7.4) and 0.1 ml of 3.5 mM NADH.
The latter mixture had been equilibrated at 37 °C within the
thermostatically heated cell housing in the ultraviolet spectrophot-
ometer (Perkin Elmer, UV/VIS, Bio 20). The change in absorbance at
340 nm was recorded for 3 min. One unit of activity is deﬁned as the
amount of enzyme that will reduce 1 μmol of pyruvate to L-lactate per
minute at pH 7.5 and 37 °C.
2.2.2. Total glutathione
The total level of glutathione in culture medium was determined
by the glutathione reductase enzymatic recycling method essentially
as described by Adams et al. [24]. The reaction buffer was prepared by
adding 16 U of glutathione reductase (GR) to 26 ml of assay buffer
(100 mM potassium phosphate and 5 mM potassium EDTA, pH 7.5).
Sample (20 μl) or GSH standard solution (up to 10 μM) was mixed
with 20 μl of buffered DTNB (10 mM DTNB in assay buffer). After
equilibration for 1 min the reaction was started by adding 20 μl of
3.6 mM NADPH, and the absorbance at 405 nm (A405) was measured
for 5 min using an OPTImax microplate reader (Molecular Devices,
Sunnyvale, CA, USA).
2.2.3. Nitrite plus nitrate
Nitrite plus nitrate were measured using a modiﬁed Griess assay
essentially according to Moody and Shaw [25]. Assay mixture was
prepared by mixing (per ml) 0.72 ml of 50 mM sodium phosphate
buffer (pH 7.4), 0.08 ml (1.6 U ml−1 nitrate reductase from Asper-
gillus niger in buffer), and 0.2 ml of 1 mM NADPH. Nitrate standard
(50 μl, up to 20 μM) or samples were mixed with 50 μl assay
mixture to give a ﬁnal concentration of 0.1 U ml−1 nitrate reductase
and 0.2 mM NADPH in the wells of a 96-well plate. The plate was
then incubated for 30 min at 20 °C to allow complete reduction of
nitrate to nitrite. The diazotization reaction was started by adding
100 μl of sulphanilamide (1% [w/v] in 1 M HCl), followed by 100 μl
of 0.1% NED 30 s later. The absorbance at 550 nm was measured a
few minutes later in a Dynatech Laboratories MRX plate reader
(Billingshurst, UK).
2.2.4. Lactate
The assay mixture contained 0.43 M glycine, 0.34 M hydrazine,
3.1 mM NAD+ and 19 U ml−1 LDH. Sample (30 μl) or lactate standard
solution (up to 2 mM) was mixed with 300 μl of assay mixture, and
then incubated at 37 °C for 30 min to complete the reaction. The
absorbance at 340 nmwas measured in a Dynatech Laboratories MRX
plate reader (Billingshurst, UK).
2.2.5. Vascular endothelial growth factor (VEGF)
Crude homogenates of each segment were made by homogenizing
about 15 mg of rat aorta tissue in 0.6 ml hypotonic Tris buffer (pH 7.4,
20 mM Tris chloride, 1 mM EDTA) in the presence of protease
inhibitors (Sigma P-2714, according to recommended usage). Tissues
were then homogenized on ice using a TD20 rotor of a CAT-X5 20 D
homogenizer at 16,000 rpm and using 3×10 second bursts to avoid
frictional heating in the samples.
VEGF levels in tissue homogenate and medium were measured
using a commercially available mouse VEGF immunoassay kit (R&D
Systems, MMV00). Because the kit has not been used before for blood
vessel homogenates, sample volume and ﬁrst binding incubation
time were optimised and validated at 50 μl and 2 h at 25 °C,
respectively (data not shown). Assays were performed in duplicate
and optical density was determined using the OPTImax microplate
reader set to 450 nm. Absorbance at 540 nm (A540) was also measured
at the same time, and A540 values were subtracted from A450 values, as
suggested in the manual to correct for optical imperfections in the
plate.
Fig. 1. Histological integrity of the in vitro blood vessel preparation in Krebs Ringer.
Sections (8 μm, stained with Mallory's trichrome) show normal histology of the vessel
wall at the end of experiments (A) air, (B) normobaric oxygen, NBO and (C) hyperbaric
oxygen, HBO treatments.
Fig. 2. Effects of medium and oxygen treatment on LDH activity in the medium
surrounding sections of rat aorta. The data are the pooled values for samples of media
taken immediately after the oxygen treatment and 4 h after. Means±S.E.M. (n=18) are
shown. ‘None’ is unsupplemented Krebs Ringer solution, whereas ‘+arg.’, ‘+lac.’ and
‘+lac. +arg.’ are Krebs Ringer supplemented with 100 μM arginine and/or 15 mM
lactate, as indicated. Oxygen treatment was for 90minwith air at 1 ATA (air) or 100% O2
at 1 ATA (NBO) or 100% O2 at 2.2 ATA. ‘1’, statistically signiﬁcant difference compared to
values seen with unsupplemented Krebs Ringer as the medium. ‘2’, statistically
signiﬁcant difference compared to values seen in the same mediumwith air treatment.
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Histological assessment was performed as part of the viability
assessment of the in vitro preparation to ensure the structure of the
endothelium and underlying layers of the blood vessel were intact. At
the end of the experiments, segments of aorta were ﬁxed in 15 ml of
Bouin's solution (75ml of 1% picric acid, 25 ml of 10% formalin, 5 ml of
glacial acetic acid) for 24 h, and then processed for routine wax
histology. Sections were cut to 8 μm and stained with Mallory's
trichrome. Sections were prepared in batches from all treatments to
eliminate staining artefact between treatments, and photographed
(Nikon E990 digital camera and Leica DM1RB light microscope) to
collect at least 3 representative images from each specimen. In
addition to general light microscopy observations on the integrity of
each specimen, some quantitative histology was performed to
measure the dimensions of the endothelium. The thickness of thetunica intima and tunica mediawas determined for each specimen (in
triplicate using Image J software). In order to correct the for the
absolute size of each blood vessel in the analysis of tunica thickness,
the data for the innermost layer (tunica intima) were expressed as a
percentage fraction of the total tunica thickness and we have called
this the “endothelium index”:
Endothelium index=thickness of tunica intima/(thickness of
tunica intima+tunica media)×100%.
2.4. Statistics
Data are shown as means±S.E.M. Statistical analysis was carried
out using Statgraphics Plus 5.1 (Statistical Graphics Corp.). Multiple
range tests (Tukey) and t tests, as appropriate, were carried out after
ANOVA in order to determine signiﬁcant differences. Throughout a P
value of b0.05 is considered signiﬁcant.
3. Results
In this study sections of rat aorta were incubated for 30 min in
either normal Krebs Ringer medium or Krebs Ringer supplemented
with lactate and/or arginine, and then subjected to 90 min of one of
three treatments: normobaric air (air at 1 ATA, ‘air’); normobaric
oxygen (100% O2 at 1 ATA, ‘NBO’); and hyperbaric oxygen (100% O2 at
2.2 ATA, ‘HBO’). After treatment the aorta sections were returned to
normobaric air for a further 4 h. The in vitro blood vessel preparation
remained viable during all experiments, as judged by the histological
integrity of the vessels at the end of the experiments (Fig. 1) and the
absence of large changes in LDH in the Krebs Ringer over 4 h (Fig. 2).
The wall of rat aorta showed a normal tunica intima (innermost, the
endothelial cell lining), tunica media (middle layer containing smooth
muscle cells), and tunica adventitia (outer layer, mainly connective
tissue). There was no evidence of tissue damage such as oedema,
Table 1
Biochemical parameters after incubation of segments of rat aorta in normal Krebs
Ringer for 30 min.
Supplementation to normal Krebs Ringer medium
None Arginine Lactate Lactate+
arginine
LDH (U g−1)a 10.3±2.3 15.0±3.3 12.3±2.0 14.5±3.2
Total glutathione
(nmol g−1)
79.8±7.8 105.0±12.0 106.8±7.2 117.0±10.2b
NOx (μmol g−1) 0.96±0.06 2.82±0.48b,c 1.62±0.18d 1.92±0.18
Tissue VEGF
(ng mg−1 protein)
0.27±0.08d 0.25±0.05 0.30±0.04 0.28±0.04
a All values are per g wet weight of tissue except for VEGF, which is per mg protein.
b Signiﬁcantly different to that in medium without supplementation.
c Signiﬁcantly different to that in medium with only lactate supplementation.
d n=8.
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supported by measurement of the endothelium index which did not
change during the experiments (ANOVA, P=0.31). For example, the
endothelium indexwas (mean±S.E.M.; n=5 rats/treatment): 2.97±
0.32, 2.59±0.27 and 2.45±0.31% for air, NBO and HBO immediately
post exposure when Krebs Ringer was used (the pre-treatment
control, 2.83±0.24%). The index did not change by 4 h post exposure
(mean±S.E.M.; n=5 rats/treatment): 2.86±0.19, 2.36±0.22 and
2.46±0.37% for air, NBO and HBO. The in vitro preparations therefore
appeared viable with normal structural integrity.
In each experiment a range of biochemical parameters was
measured after the initial 30 min incubation (pre-exposure; ‘Pre’);
after the oxygen treatment (post exposure; ‘Post’); and again 4 h after
the treatment (4 h post exposure; ‘4 h Post’) in either the medium or,
in the case of VEGF, in tissue homogenate. Table 1 shows the ‘Pre’
values for these biochemical parameters. There were no signiﬁcant
differences in LDH activities in the four media at this point, or in tissue
VEGF levels. VEGF in the media was below the detection limit of the
assay method used. At this point (‘Pre’ values) total glutathione levels
were higher in the supplemented media compared to the unsupple-Fig. 3. Effects of medium and oxygen treatment on total glutathione in themedium surroundi
treatment. Means±S.E.M. (n=9) are shown. ‘None’ is unsupplemented Krebs Ringer solutio
arginine and/or 15 mM lactate, as indicated. Oxygen treatment was for 90 min with air at 1
difference compared to values seen with unsupplemented Krebs Ringer as the medium. ‘2’, s
treatment. ‘3’ statistically signiﬁcant difference compared to values seen in the same mediumented medium, but the difference was only signiﬁcant (Pb0.05) for
the lactate+arginine supplemented medium. NOx levels were higher
in media supplemented with arginine; where NOx levels were
signiﬁcantly higher than in the two media without arginine
supplementation (Pb0.05).
For each biochemical parameter shown in Table 1, and also
medium lactate levels, the ‘Post’ and ‘4 h Post’ data were analysed
using multifactorial ANOVA with medium (no supplementation,
‘none’; plus arginine, ‘+arg.’; plus lactate, ‘+lac.’; and plus lactate
and arginine, ‘+lac. +arg.’), oxygen treatment (‘air’, ‘NBO’ and ‘HBO’)
and time (‘Post’ and ‘4 h Post’) as factors, and initially including the
three second order interactions between these factors. In each case, if
after the initial analysis one or more of these interactions was found to
be insigniﬁcant, they were omitted and the data were re-analysed.
There was no signiﬁcant effect of time on medium lactate
dehydrogenase (LDH) levels, but the effects of type of medium and
treatment were both signiﬁcant (Pb0.00005) as was the interaction
between type of medium and treatment (P=0.0219). Since there was
no effect of time on medium LDH the ‘Post’ and ‘4 h Post’ data were
pooled. Fig. 2 shows a plot of the pooled LDH data for each medium
and each oxygen treatment. The pattern of LDH release for each
medium is broadly the same as that seen in the ‘Pre’ data (Table 1),
with medium LDH levels being signiﬁcantly higher in all the
supplemented media compared to the unsupplemented Krebs Ringer.
Exposure to 100% O2, either normobaric (‘NBO’) or hyperbaric (‘HBO’),
caused signiﬁcant elevation of medium LDH in the supplemented
Krebs Ringer, but not in the unsupplemented medium.
There were signiﬁcant effects of all factors on total glutathione
levels in the medium (Pb0.00005 for medium; Pb0.00005 for
treatment; and P=0.0239 for time), and there was an interaction
between medium and treatment (P=0.0135). Fig. 3 shows plots of
total glutathione for each medium and each oxygen treatment
immediately after the oxygen treatment (‘Post’) and again, 4 h after
(‘4 h Post’). Glutathione levels were higher in the media supplemen-
tedwith lactate and/or arginine, andwere also slightly higher 4 h post
treatment compared to immediately post treatment. Exposure to 100%ng sections of rat aorta. Left panel, immediately post treatment, and right panel, 4 h post
n, whereas ‘+arg.’, ‘+lac.’ and ‘+lac. +arg.’ are Krebs Ringer supplementedwith 100 μM
ATA (air) or 100% O2 at 1 ATA (NBO) or 100% O2 at 2.2 ATA. ‘1’, statistically signiﬁcant
tatistically signiﬁcant difference compared to values seen in the same mediumwith air
m with normobaric oxygen treatment.
Fig. 5. Effects of medium composition on lactate in the medium surrounding sections of
rat aorta immediately (‘Post’) and 4 h post (‘4 h Post’) oxygen treatment compared to
lactate levels immediately before (‘Pre’) oxygen treatment. The data from all of the
oxygen treatments are pooled. Means±S.E.M. (n=27) are shown. ‘None’ is
unsupplemented Krebs Ringer solution, whereas ‘+arg.’, ‘+lac.’ and ‘+lac. +arg.’ are
Krebs Ringer supplemented with 100 μM arginine and/or 15 mM lactate, as indicated.
‘1’, statistically signiﬁcant difference compared to values seen immediately post
treatment (‘Post’–‘Pre’). ‘2’, statistically signiﬁcant difference compared to values seen
in unsupplemented Krebs Ringer. ‘3’, statistically signiﬁcant difference compared to
values seen in Krebs Ringer supplemented with lactate.
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cant elevation of medium glutathione in the supplemented Krebs
Ringer, but not in the unsupplemented medium.
There was a signiﬁcant effect of medium supplementation on NOx
(nitrate, NO3− plus nitrite, NO2−) levels (P=0.0007; Fig. 4) but not of
oxygen treatment or time. NOx levels were higher in the media
supplemented with lactate and/or arginine than in the unsupple-
mented Krebs Ringer.
Lactate levels were measured in the media at all three time points
(‘Pre’, ‘Post’ and ‘4 h Post’). However, they are not reported in Table 1
(‘Pre’ data) because of the high levels of lactate with which two of the
media were supplemented. It was therefore difﬁcult to judge whether
or not there had been any further accumulation of lactate in these
media at that point. Nevertheless, for the later time points it was
possible to include the change in lactate in the media compared to the
levels immediately before the oxygen treatment. There were sig-
niﬁcant effects of medium and time on lactate accumulation
(P=0.0007 and Pb0.00005, respectively) (Fig. 5). Immediately post
treatment (‘Post’–‘Pre’) there had been accumulation of lactate in all
the media except for the medium supplemented with lactate alone,
where there was a slight decrease. Accumulation of lactate was
greatest in the media supplemented with arginine. However, by 4 h
post treatment (‘4 h Post’–‘Pre’) there had been accumulation of
lactate in all the media, but more so in the media supplemented with
arginine, and in particular the medium supplemented with both
lactate and arginine.
There was no signiﬁcant effect of oxygen treatment on tissue VEGF
levels. However, there were signiﬁcant effects of both medium and
time (P=0.0001 and Pb0.00005, respectively). Since there was no
effect of treatment on tissue VEGF the data for the different treatments
were pooled. Fig. 6 shows a plot of the pooled VEGF data for each
medium and each time. Tissue VEGF levels were signiﬁcantly higher
4 h after oxygen treatment (‘4 h Post’) than immediately after
treatment (‘Post’), but they were signiﬁcantly lower at both time
points in the media supplemented with lactate.Fig. 4. Effect of medium on NOx (NO2−+ NO3−) in the medium surrounding sections of
rat aorta. The data are the pooled values for samples of media taken immediately after
the oxygen treatment and 4 h after, irrespective of oxygen treatment. Means±S.E.M.
(n=54) are shown. ‘None’ is unsupplemented Krebs Ringer solution, whereas ‘+arg.’,
‘+lac.’ and ‘+lac. +arg.’ are Krebs Ringer supplemented with 100 μM arginine and/or
15 mM lactate, as indicated. ‘1’, statistically signiﬁcant difference compared to values
seen with unsupplemented Krebs Ringer as the medium.
Fig. 6. Effects of medium composition on VEGF levels in sections of rat aorta
immediately (‘Post’) and 4 h post (‘4 h Post’) oxygen treatment. The data from all of
the oxygen treatments are pooled. Means±S.E.M. (n=27) are shown. ‘None’ is
unsupplemented Krebs Ringer solution, whereas ‘+arg.’, ‘+lac.’ and ‘+lac. +arg.’ are
Krebs Ringer supplemented with 100 μM arginine and/or 15 mM lactate, as indicated.
‘1’, statistically signiﬁcant difference compared to values seen immediately post
treatment (‘Post’). ‘2’, statistically signiﬁcant difference compared to values seen in
unsupplemented Krebs Ringer.
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In this study, we used an in vitro aortic vessel preparation to
investigate the effects of HBO on NOx and VEGF production by the
tissue, and to assess tissue damage via LDH release into the medium.
For the ﬁrst time, we also explore these effects in a Krebs Ringer that
mimics the chemical conditions in a chronic wound situation. Overall,
we have shown that a single 90 min therapeutic HBO treatment at 2.2
ATA in normal Krebs Ringer does not induce signiﬁcant oxidative
stress or damage the tissue, as evidenced by very low levels of LDH
leak, and modest depletion of total glutathione pools (Table 1, Figs. 2
and 3). However, there is also no evidence of HBO-dependent NO or
VEGF production in normal Krebs Ringer (no supplement, Table 1).
Nonetheless, when the Krebs Ringers were supplementedwith lactate
to mimic wound conditions, or arginine to promote NO synthesis,
statistically signiﬁcant increases in LDH release, and glutathione
depletion were observed in HBO groups (Figs. 2 and 3); along with
some decrease in tissue VEGF mainly in the +lac, lac + arg media
(Fig. 6), and increased NOx production (Fig. 4). Thus we show that the
response of the tissue is subtly affected by the chemical environment
around the blood vessel, and the tissue is more responsive to HBO
when wound conditions are mimicked.
This experiment, to our knowledge, is the ﬁrst time an isolated in
vitro blood vessel preparation has been used to investigate the effects
of HBO therapy. One concern is that ROS production during HBO
therapy will damage any in vitro preparation, but this does not seem
to be the case in our experiment. In normal Krebs Ringer, the LDH leak
into the medium was low (Table 1), and histological examination of
vessels at the end of the experiment also conﬁrmed normal structure
of the tissue (Fig. 1). At the same time, total glutathione measure-
ments in the medium suggested only small changes in tissue
glutathione (Table 1) and therefore minimal loss of this antioxidant.
In addition, there were no effects of oxygen or HBO on any of these
parameters (Table 1, Figs. 2 and 3), suggesting that a single 90 min
HBO treatment at 2.2 ATA does not induce oxidative stress or have
adverse effects on this in vitro preparation. This ﬁnding is consistent
with reports on blood from our patients [14] and biochemical
investigations on blood platelets in vitro [15]. Together, this suggests
that the in vitro blood vessel preparationwas viable, and is a good tool
for investigating the local effects of HBO on blood vessels.
VEGF has been suggested to have a pivotal role in promoting
angiogenesis [e.g., 7, 8]. However, the evidence for its direct activation
during hyperbaric conditions is controversial, not least because
experiments on rats show that there is a delay in VEGF production
during repeated daily HBO treatments (40% rise in VEGF after 5 days
during a twice daily regime of 90 min HBO at 2.1 ATA for 7 days), and
any rise in VEGF is quickly lost (within 3 days) after HBO therapy [4].
In vitro studies on human umbilical vein endothelial cells show no
effect of HBO on VEGF expression [26]. Similarly, in our experiments,
there was no oxygen or HBO-dependent change in tissue VEGF when
using normal Krebs Ringer, and VEGF levels in the medium remained
below the detection limit (b3 pg ml−1). Nitric oxide appears to be
important for the induction of VEGF during wound healing [13], and it
was theoretically possible that low NO production was limiting VEGF
release from our in vitro preparation when normal Krebs Ringer was
used. However, supplementation with a physiological level of L-
arginine (100 μM for rat plasma, [20]) did not alter the ﬁndings for
VEGF. L-arginine supplementation has been used in endothelial cell
cultures to promote the synthesis of NO [27], and this was clearly
successful in our experiments because NOx levels increased with L-
arginine supplementation (Fig. 4). Overall, in our experimental
conditions, neither normobaric oxygen nor HBO treatment alters
VEGF levels in the tissue.
Chronic wounds often suffer from insufﬁcient oxygen supply,
which can cause large concentrations of lactate (10–25 mM) to
accumulate in the wound during anaerobic energy production [21,22].It has been suggested that these abnormally high levels of lactate can
initiate angiogenesis, and the release of regulatory factors including
VEGF [28–30]. Lactate supplementation had no effect on tissue VEGF
at the beginning (Table 1) or end of the experiment (Fig. 6), and no
effects on NOx production (Fig. 4). Our experiment therefore does not
support the notion of a local effect of lactate on the blood vessel, but
we cannot exclude other systemic effects of lactate (not local at the
wound site).
Lactate supplementation had no effect on lactate production in the
air, NBO or HBO treated groups. Sheikh et al. [4] also found that HBO
did not affect lactate levels in wounds. However, supplementing the
medium with lactate did slow down the rate of lactate release from
the tissue (Fig. 5), regardless of air, oxygen or HBO treatment. This
might be explained in part to a small loss of tissue LDH activity
(increasing in the medium, Fig. 2), but is more likely due to the added
external lactate slowing the net efﬂux of lactate from the endothelial
cell (monocarboxylate transporters saturated for lactate uptake, Km
around 2–3 mM, [31]).
Lactate supplementation did reveal a HBO treatment-dependent
effect on bothmedium LDH levels and total glutathione (Figs. 2 and 3).
After, HBO treatment the glutathione and LDH release to the medium
was statistically higher than the air controls, and for glutathione, also
higher than the normobaric oxygen treatment. This suggests the in
vitro preparation is more leaky to LDH and glutathione after HBO, but
these are very small changes (e.g., b20 μmol g−1 tissue for total
glutathione) and not likely to be of toxicological signiﬁcance.
The wound environment can have both high levels of lactate and
NO in vivo, and the role of NO has been explained in terms of its
vasodilatory effects to enable access of the immune system and
inﬂammatory factors to the wound site, and then later on, to promote
angiogenesis [13]. It is therefore possible, that several beneﬁcial
effects of HBO are driven by the particular combination of metabolites
present in thewound, and that any one chemical aspect alone (lactate,
NO, wound hypoxia etc.) is not sufﬁcient to trigger HBO-dependent
angiogenesis. In this study, we also included a combined supplement
of lactate plus L-arginine. This combined supplement had no effect on
VEGF (Table 1. Fig. 6) or NOx production (Fig. 4), and overall produced
similar changes in LDH and glutathione levels in the medium to the
lactate treatment alone (Figs. 2 and 3). There was no indication of an
additive effective of these supplements.
In conclusion, we have demonstrated an in vitro blood vessel
preparation for investigating the effects of HBO on blood vessels. The
data suggests that HBO therapy does not cause VEGF release locally
from the blood vessels used, or changes in NOx. Although VEGF release
was not stimulated by supplementing media with L-arginine, the
effects of lactate, and/or arginine supplementation on changes in
glutathione and LDH release suggest that using a medium that mimics
the wound environment reveals effects of HBO therapy that are not
seen in normal physiological solutions.
Acknowledgements
This project was ﬁnancially supported by the University of
Plymouth and the Diving Diseases Research Centre, Plymouth, UK.
Wewould like to thank Dr Gary Smerdon for helpful comments on the
manuscript.
References
[1] R.E. Marx, W.J. Ehler, P. Tayapongasak, L.W. Pierce, Relationship of oxygen dose to
angiogenesis induction in irradiated tissue, Am. J. Surg. 160 (1990) 519–524.
[2] A. Mechine, S. Rohr, F. Toti, C. Aysoy, F. Schneider, C. Meyer, J.D. Tempe, J.P. Bellocq,
Wound healing and hyperbaric oxygen. Experimental study of the angiogenesis
phase in the rat, Ann. Chir. 53 (1999) 307–313.
[3] A. Muhonen, M. Haaparanta, T. Gronroos, J. Bergman, J. Knuuti, S. Hinkka, R.-P.
Happonen, Osteoblastic activity and neoangiogenesis in distracted bone of
irradiated rabbit mandible with or without hyperbaric oxygen treatment, Int. J.
Oral Max. Surg. 33 (2004) 173–178.
834 J. Yuan et al. / Biochimica et Biophysica Acta 1787 (2009) 828–834[4] A.Y. Sheikh, M.D. Rollins, H.W. Hopf, T.K. Hunt, Hyperoxia improves microvascular
perfusion in a murine wound model, Wound Repair Regen. 13 (2005) 303–308.
[5] G. Neufeld, T. Cohen, S. Gengrinovitch, Z. Poltorak, Vascular endothelial growth
factor (VEGF) and its receptors, FASEB J. 13 (1999) 9–22.
[6] I. Zachary, G. Gliki, Signaling transduction mechanism mediating biological
actions of the vascular endothelial growth factor family, Cardiovasc. Res. 49
(2001) 568–581.
[7] E. Hormbrey, P. Gillespie, K. Turner, C. Han, A. Roberts, D. McGrouther, A.L. Harris, A
critical review of vascular endothelial growth factor (VEGF) analysis in peripheral
blood: is the current literature meaningful? Clin. Exp. Metastasis 19 (2002)
651–663.
[8] N. Ferrara, H.P. Gerber, J. LeCouter, The biology of VEGF and its receptors, Nat. Med.
9 (2003) 669–676.
[9] G.M. Gordillo, S. Roy, S. Khanna, R. Schlanger, S. Khandelwal, G. Phillips, C.K. Sen,
Topical oxygen therapy induces vascular endothelial growth factor expression and
improves closure of clinically presented chronic wounds, Clin. Exp. Pharm.
Physiol. 35 (2008) 957–964.
[10] J. Niinikoski, Current concepts of the role of oxygen in wound healing, Ann. Chir.
Gynaecol. Suppl 215 (2001) 9–11.
[11] W.A. Zamboni, L.K. Browder, J. Martinez, Hyperbaric oxygen and wound healing,
Clin. Plastic Surg. 30 (2003) 67–75.
[12] J. Gutteridge, Biological origin of free radicals, and mechanisms of antioxidant
protection, Chem. Biol. Interact. 91 (1994) 133–140.
[13] J.D. Luo, A.F. Chen, Nitric oxide: a newly discovered function on wound healing,
Acta Pharmacol. Sin. 26 (2005) 259–264.
[14] R.D. Handy, P. Bryson, A.J. Moody, L.M. Handy, J.R. Sneyd, Oxidative metabolism in
platelets, platelet aggregation, and hematology in patients undergoing multiple
hyperbaric oxygen exposures, Undersea Hyperb. Med. 32 (2005) 327–340.
[15] F.L. Shaw, R.D. Handy, P. Bryson, J.R. Sneyd, A.J. Moody, A single exposure to
hyperbaric oxygen does not cause oxidative stress in isolated platelets: no effect
on superoxide dismutase, catalase, or cellular ATP, Clin. Biochem. 38 (2005)
722–726.
[16] C.K. Sen, S. Khanna, G. Gordillo, D. Bagchi, M. Bagchi, S. Roy, Oxygen, oxidants, and
antioxidants in wound healing, An emerging paradigm, Ann. N.Y. Acad. Sci. 956
(2002) 239–249.
[17] C.K. Sen, S. Khanna, B.M. Babior, T.K. Hunt, E.C. Ellison, S. Roy, Oxidative-induced
vascular endothelial growth factor expression in human keratinocytes and
cutaneous wound healing, J. Biol. Chem. 277 (2002) 33284–33290.[18] S.J. Kirk, M. Hurson, M.C. Regan, D.R. Holt, H.L. Wasserkrug, A. Barbul, Arginine
stimulates wound healing and immune function in elderly human beings, Surgery
114 (1993) 155–160.
[19] R.E. Abbott, D. Schachter, Regional differentiation in rat aorta: L-arginine
metabolism and cGMP content in vitro, Am. J. Physiol. 266 (1994) H2287–H2295.
[20] S. Osowska, C. Moinard, C. Loi, N. Neveux, L. Cynober, Citrulline increases arginine
pools and restores nitrogen balance after massive intestinal resection, Gut 53
(2004) 1781–1786.
[21] M.J. Im, J.E. Hoopes, Enzyme activities in the repairing epithelium during wound
healing, J. Surg. Res. 10 (1970) 173–179.
[22] T.K. Hunt, M.J. Banda, I.A. Silver, Cell interaction in post-traumatic ﬁbrosis, Ciba
Found. Symp. 114 (1985) 127–149.
[23] D.T. Plummer, An Introduction to Practical Biochemistry, McGraw Hill, London,
1971, pp. 238–240.
[24] J.D. Adams, B.H. Lauterburg, J.R. Mitchell, Plasma glutathione and glutathione
disulﬁde in the rat: regulation and response to oxidative stress, J. Pharmacol. Exp.
Ther. 227 (1983) 749–754.
[25] A.J. Moody, F.L. Shaw, Re-evaluation of the Greiss reaction: howmuch of a problem
is interference by nicotinamide nucleotides? Anal. Biochem. 356 (2006) 154–156.
[26] S. Lin, K.G. Shyu, C.C. Lee, B.W. Wang, C.C. Chang, Y.C. Liu, F.Y. Huang, H. Chang,
Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein
endothelial cells, Biochem. Biophys. Res. Commun. 296 (2002) 710–715.
[27] R.M.J. Palmer, D.D. Rees, D.S. Ashton, S. Moncada, L-arginine is the physiological
precursor for the formation of nitric oxide in endothelium-dependent relaxation,
Biochem. Biophys. Res. Commun. 153 (1988) 1251–1256.
[28] J.A. Jensen, T.K. Hunt, H. Scheuenstuhl, M.J. Banda, Effect of lactate, pyruvate, and
pH on secretion of angiogenesis and mitogenesis factors by macrophages, Lab.
Invest. 54 (1986) 574–578.
[29] D.D. Zabel, J.J. Feng, H. Scheuenstuhl, T.K. Hunt, M.Z. Hussain, Lactate stimulation
of macrophage-derived angiogenic activity is associated with inhibition of Poly
(ADP-ribose) synthesis, Lab. Invest. 74 (1996) 644–649.
[30] J.S. Constant, J.J. Feng, D.D. Zabel, H. Yuan, D.Y. Suh, H. Scheuenstuhl, T.K. Hunt,
M.Z. Hussain, Lactate elicits vascular endothelial growth factor from macrophages:
a possible alternative to hypoxia, Wound Repair Regen. 8 (2000) 353–360.
[31] R.C. Poole, A.P. Halestrap, S.J. Price, A.J. Levi, The kinetics of transport of lactate and
pyruvate into isolated cardiac myocytes from Guinea-pig — kinetic evidence for
the presence of a carrier distinct from that in erythrocytes and hepatocytes,
Biochem. J. 264 (1989) 409–418.
